Over-the-Counter Drug Monograph Reform Legislation in the 116th Congress
Update Magazine | April/May 2019
Communicating with FDA When Data Integrity Issues Arise During Clinical Trials
Update Magazine | April/May 2019
Global Regulatory Focus | China: Survival of the Fittest or Cheapest
Update Magazine | April/May 2019
Single, Shared System Risk Evaluation and Mitigation Strategies: Opportunities and Challenges
Recorded May 14, 2019 | On-Demand Webinar
FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law
May 2–3, 2019 | Washington, DC
Toward a Global Solution on Vaccine Liability and Compensation (Open Access)
Food and Drug Law Journal | Volume 74 | Number 1
The Fountain of Youth Revisited: Regulatory Challenges and Pathways for Healthspan Promoting Interventions
Food and Drug Law Journal | Volume 74 | Number 1
Blurred Lines: The Collapse of the Research/Clinical Care Divide and the Need for Context-Based Research Categories in the Revised Common Rule (Open Access) GalleryBlurred Lines: The Collapse of the Research/Clinical Care Divide and the Need for Context-Based Research Categories in the Revised Common Rule (Open Access)
Blurred Lines: The Collapse of the Research/Clinical Care Divide and the Need for Context-Based Research Categories in the Revised Common Rule (Open Access)
Food and Drug Law Journal | Volume 74 | Number 1
“Left To Our Own Devices, What Did We Get Wrong?” The Medical Device Amendments of 1976 as Seen from the Insider’s View
Food and Drug Law Journal | Volume 74 | Number 1
Left to Their Own Devices: How the Dangers of Power Morcellators Went Undetected by FDA for Two Decades
Food and Drug Law Journal | Volume 74 | Number 1
